ch-vacd-immunoglobulin-targetdiseases-cm
type: ConceptMap
node role: treeRoot
id:
  v: ch-vacd-immunoglobulin-targetdiseases-cm
text:
  status:
    v: generated
  div:
    v: Generated Narrative: ConceptMap ch-vacd-immunoglobulin-targetdiseases-cm Mapping from CH VACD Swissmedic Authorized Immunoglobulin Codes to CH VACD Target disease and illnesses undergone for immunization Group 1 Mapping from CH VACD Swissmedic Authorized Immunoglobulin Codes to SNOMED CT (all versions) Source Concept Details Relationship Target Concept Details Codes from CH VACD Swissmedic Authorized Immunoglobulin Codes Codes from SNOMED CT (all versions) 00687-01 Berirab 2 ml, Injektionslösung is related to 14168008 Rabies (disorder) 00687-02 Berirab 5 ml, Injektionslösung is related to 14168008 Rabies (disorder) 69039-02 Beyfortus 100 mg/1 ml, solution injectable en seringue préremplie is related to 55735004 Respiratory syncytial virus infection (disorder) 69039-01 Beyfortus 50 mg/0.5 ml, solution injectable en seringue préremplie is related to 55735004 Respiratory syncytial virus infection (disorder) 68222-01 Cutaquig 165 mg/ml, Injektionslösung is related to 58606001 Primary immune deficiency disorder (disorder) is related to 33286000 Secondary immune deficiency disorder (disorder) 65992-01 Cuvitru 200 mg/ml, Injektionslösung is related to 58606001 Primary immune deficiency disorder (disorder) is related to 33286000 Secondary immune deficiency disorder (disorder) 00506-02 Cytotect CP Biotest, Infusionslösung is related to 28944009 Infection caused by Cytomegalovirus (disorder) 00701-02 Gammanorm, Injektionslösung is related to 58606001 Primary immune deficiency disorder (disorder) is related to 16318001000119107 Hypogammaglobulinemia due to multiple myeloma (disorder) 00668-01 Gamunex 10%, solution pour injection intraveineuse is related to 14189004 Measles (disorder) 00488-02 Hepatect CP, Infusionslösung is related to 66071002 Viral hepatitis type B (disorder) 00674-01 Hepatitis-B-Immunglobulin Behring, Injektionslösung is related to 66071002 Viral hepatitis type B (disorder) 66410-01 Hizentra 200mg/ml, Injektionslösung zur s.c. Anwendung, Fertigspritze is rel…
url:
  v: http://fhir.ch/ig/ch-vacd/ConceptMap/ch-vacd-immunoglobulin-targetdiseases-cm
  l: ch-vacd-immunoglobulin-targetdiseases-cm
version:
  v: 3.4.0
name:
  v: ImmunGlobulineToTargetDiseaseMapping
title:
  v: ImmunGlobuline To TargetDisease Mapping
status:
  v: active
experimental:
  v: false
date:
  v: 2026-06-10T09:49:50+00:00
publisher:
  v: HL7 Switzerland
contact:
  name:
    v: HL7 Switzerland
  telecom:
    system:
      v: url
    value:
      v: https://www.hl7.ch/
contact:
  name:
    v: HL7 Switzerland
  telecom:
    system:
      v: url
    value:
      v: https://www.hl7.ch/
    use:
      v: work
description:
  v: Mappings from ImmunGlobuline to TargetDisease according to the correcsponding valuesets
jurisdiction:
  coding:
    system:
      v: urn:iso:std:iso:3166
      l: 3166
    code:
      v: CH
copyright:
  v: This artefact includes content from SNOMED Clinical Terms® (SNOMED CT®) which is copyright of the International Health Terminology Standards Development Organisation (IHTSDO). Implementers of these artefacts must have the appropriate SNOMED CT Affiliate license - for more information contact http://www.snomed.org/snomed-ct/getsnomed-ct or info@snomed.org.
source: Uri
  v: http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-swissmedic-immunoglobulin-vs
  l: ch-vacd-swissmedic-immunoglobulin-vs
target: Uri
  v: http://fhir.ch/ig/ch-vacd/ValueSet/ch-vacd-targetdiseasesandillnessesundergoneforimmunization-vs
  l: ch-vacd-targetdiseasesandillnessesundergoneforimmunization-vs
group:
  source:
    v: http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-swissmedic-immunoglobulin-cs
    l: ch-vacd-swissmedic-immunoglobulin-cs
  target:
    v: http://snomed.info/sct
    l: sct
  element:
    code:
      v: 00687-01
    display:
      v: Berirab 2 ml, Injektionslösung
    target:
      code:
        v: 14168008
      display:
        v: Rabies (disorder)
      equivalence:
        v: relatedto
  element:
    code:
      v: 00687-02
    display:
      v: Berirab 5 ml, Injektionslösung
    target:
      code:
        v: 14168008
      display:
        v: Rabies (disorder)
      equivalence:
        v: relatedto
  element:
    code:
      v: 69039-02
    display:
      v: Beyfortus 100 mg/1 ml, solution injectable en seringue préremplie
    target:
      code:
        v: 55735004
      display:
        v: Respiratory syncytial virus infection (disorder)
      equivalence:
        v: relatedto
  element:
    code:
      v: 69039-01
    display:
      v: Beyfortus 50 mg/0.5 ml, solution injectable en seringue préremplie
    target:
      code:
        v: 55735004
      display:
        v: Respiratory syncytial virus infection (disorder)
      equivalence:
        v: relatedto
  element:
    code:
      v: 68222-01
    display:
      v: Cutaquig 165 mg/ml, Injektionslösung
    target:
      code:
        v: 58606001
      display:
        v: Primary immune deficiency disorder (disorder)
      equivalence:
        v: relatedto
    target:
      code:
        v: 33286000
      display:
        v: Secondary immune deficiency disorder (disorder)
      equivalence:
        v: relatedto
  element:
    code:
      v: 65992-01
    display:
      v: Cuvitru 200 mg/ml, Injektionslösung
    target:
      code:
        v: 58606001
      display:
        v: Primary immune deficiency disorder (disorder)
      equivalence:
        v: relatedto
    target:
      code:
        v: 33286000
      display:
        v: Secondary immune deficiency disorder (disorder)
      equivalence:
        v: relatedto
  element:
    code:
      v: 00506-02
    display:
      v: Cytotect CP Biotest, Infusionslösung
    target:
      code:
        v: 28944009
      display:
        v: Infection caused by Cytomegalovirus (disorder)
      equivalence:
        v: relatedto
  element:
    code:
      v: 00701-02
    display:
      v: Gammanorm, Injektionslösung
    target:
      code:
        v: 58606001
      display:
        v: Primary immune deficiency disorder (disorder)
      equivalence:
        v: relatedto
    target:
      code:
        v: 16318001000119107
      display:
        v: Hypogammaglobulinemia due to multiple myeloma (disorder)
      equivalence:
        v: relatedto
  element:
    code:
      v: 00668-01
    display:
      v: Gamunex 10%, solution pour injection intraveineuse
    target:
      code:
        v: 14189004
      display:
        v: Measles (disorder)
      equivalence:
        v: relatedto
  element:
    code:
      v: 00488-02
    display:
      v: Hepatect CP, Infusionslösung

code:
  v: 66071002
display:
  v: Viral hepatitis type B (disorder)
equivalence:
  v: relatedto

code:
  v: 00674-01
display:
  v: Hepatitis-B-Immunglobulin Behring, Injektionslösung
target:
  code:
    v: 66071002
  display:
    v: Viral hepatitis type B (disorder)
  equivalence:
    v: relatedto

code:
  v: 66410-01
display:
  v: Hizentra 200mg/ml, Injektionslösung zur s.c. Anwendung, Fertigspritze
target:
  code:
    v: 58606001
  display:
    v: Primary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto
target:
  code:
    v: 33286000
  display:
    v: Secondary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto

code:
  v: 61547-01
display:
  v: Hizentra, Injektionslösung zur s.c. Anwendung
target:
  code:
    v: 58606001
  display:
    v: Primary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto
target:
  code:
    v: 33286000
  display:
    v: Secondary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto

code:
  v: 66684-01
display:
  v: HyQvia 100 mg/ml, Infusionslösung zur subkutanen Anwendung
target:
  code:
    v: 58606001
  display:
    v: Primary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto
target:
  code:
    v: 33286000
  display:
    v: Secondary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto

code:
  v: 58157-01
display:
  v: Ig Vena Kedrion 50 g/I, solution pour infusion
target:
  code:
    v: 58606001
  display:
    v: Primary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto
target:
  code:
    v: 33286000
  display:
    v: Secondary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto

code:
  v: 62913-01
display:
  v: Intratect 10%, Infusionslösung
target:
  code:
    v: 58606001
  display:
    v: Primary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto
target:
  code:
    v: 33286000
  display:
    v: Secondary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto

code:
  v: 57676-01
display:
  v: Intratect 5%, Infusionslösung
target:
  code:
    v: 58606001
  display:
    v: Primary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto
target:
  code:
    v: 33286000
  display:
    v: Secondary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto

code:
  v: 66332-03
display:
  v: Iqymune 10g/100ml, Infusionslösung
target:
  code:
    v: 58606001
  display:
    v: Primary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto
target:
  code:
    v: 33286000
  display:
    v: Secondary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto

code:
  v: 66332-04
display:
  v: Iqymune 20g/200ml, Infusionslösung
target:
  code:
    v: 58606001
  display:
    v: Primary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto
target:
  code:
    v: 33286000
  display:
    v: Secondary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto

code:
  v: 66332-01
display:
  v: Iqymune 2g/20ml, Infusionslösung
target:
  code:
    v: 58606001
  display:
    v: Primary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto
target:
  code:
    v: 33286000
  display:
    v: Secondary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto

code:
  v: 66332-02
display:
  v: Iqymune 5g/50ml, Infusionslösung
target:
  code:
    v: 58606001
  display:
    v: Primary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto
target:
  code:
    v: 33286000
  display:
    v: Secondary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto

code:
  v: 57469-01
display:
  v: Kiovig, Infusionslösung
target:
  code:
    v: 58606001
  display:
    v: Primary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto
target:
  code:
    v: 33286000
  display:
    v: Secondary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto

code:
  v: 60323-01
display:
  v: Octagam 10 %, Lösung zur intravenösen Anwendung
target:
  code:
    v: 58606001
  display:
    v: Primary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto
target:
  code:
    v: 33286000
  display:
    v: Secondary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto

code:
  v: 58314-01
display:
  v: Privigen, Infusionslösung
target:
  code:
    v: 58606001
  display:
    v: Primary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto
target:
  code:
    v: 33286000
  display:
    v: Secondary immune deficiency disorder (disorder)
  equivalence:
    v: relatedto

code:
  v: 53609-02
display:
  v: Rhophylac 300, Injektionslösung
target:
  code:
    v: 165746003
  display:
    v: RhD negative (finding)
  equivalence:
    v: relatedto

code:
  v: 65695-02
display:
  v: Synagis 100 mg/1 ml, Injektionslösung
target:
  code:
    v: 55735004
  display:
    v: Respiratory syncytial virus infection (disorder)
  equivalence:
    v: relatedto

code:
  v: 65695-01
display:
  v: Synagis 50 mg/0.5 ml, Injektionslösung
target:
  code:
    v: 55735004
  display:
    v: Respiratory syncytial virus infection (disorder)
  equivalence:
    v: relatedto

code:
  v: 00673-02
display:
  v: Tetagam P, Injektionslösung
target:
  code:
    v: 76902006
  display:
    v: Tetanus (disorder)
  equivalence:
    v: relatedto

code:
  v: 59374-01
display:
  v: Uman Big 180 UI/1 ml, solution pour injection intramusculaire
target:
  code:
    v: 66071002
  display:
    v: Viral hepatitis type B (disorder)
  equivalence:
    v: relatedto

code:
  v: 59374-02
display:
  v: Uman Big 540 UI/3 ml, solution pour injection intramusculaire
target:
  code:
    v: 66071002
  display:
    v: Viral hepatitis type B (disorder)
  equivalence:
    v: relatedto

code:
  v: 59451-01
display:
  v: Varitect CP, Lösung zur intravenösen Injektion
target:
  code:
    v: 38907003
  display:
    v: Varicella (disorder)
  equivalence:
    v: relatedto

code:
  v: 59373-02
display:
  v: Venbig 2500 U.I/50 ml, poudre et solution pour injection intraveineuse
target:
  code:
    v: 66071002
  display:
    v: Viral hepatitis type B (disorder)
  equivalence:
    v: relatedto

code:
  v: 59373-01
display:
  v: Venbig 500 U.I/10 ml, poudre et solution pour injection intraveineuse
target:
  code:
    v: 66071002
  display:
    v: Viral hepatitis type B (disorder)
  equivalence:
    v: relatedto

code:
  v: 68471-01
display:
  v: Xevudy, Konzentrat zur Herstellung einer Infusionslösung
target:
  code:
    v: 840539006
  display:
    v: Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder)
  equivalence:
    v: relatedto

code:
  v: 66344-01
display:
  v: Zinplava, Konzentrat zur Herstellung einer Infusionslösung
target:
  code:
    v: 56688005
  display:
    v: Clostridial infection (disorder)
  equivalence:
    v: relatedto

code:
  v: 61639-01
display:
  v: Zutectra, Injektionslösung
target:
  code:
    v: 66071002
  display:
    v: Viral hepatitis type B (disorder)
  equivalence:
    v: relatedto